Guanmin Yuan
Shanghai Key Laboratory Of Infectious Diseases And Biosafety Emergency Response
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Retraction notice to "Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism" [Int. J. Biol. Macromol. 281 (2024) 136183].
Journal: International journal of biological macromolecules
Published: July 21, 2026
Natural history of latent brucellosis and diagnostic performance of B-SPOT: a 24-month prospective cohort study based on large-scale screening in northern China.
Journal: Emerging microbes & infections
Published: March 17, 2026
Clinical characteristics and prognostic factors in patients with fever of unknown origin who developed secondary haemophagocytic lymphohistiocytosis.
Journal: Annals of hematology
Published: August 11, 2024
Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism.
Journal: International journal of biological macromolecules
Published: August 06, 2024
Integrated multi-omics characterization across clinically relevant subgroups of long COVID.
Journal: National science review
Published: August 03, 2024
The High Expression of PD-1 Defines A Subpopulation of Tfh Cells Responding to COVID-19 Vaccine in Humans.
Journal: Genomics, proteomics & bioinformatics
Published: July 15, 2024
Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014-2019.
Journal: Foodborne pathogens and disease
Published: April 12, 2024
Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity.
Journal: Journal of translational medicine
Published: March 22, 2024
Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.
Journal: Emerging microbes & infections
Published: December 06, 2023
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1.
Journal: Emerging microbes & infections
Published: September 05, 2023
Proteomic and Cellular Characterization of Omicron Breakthrough Infections and a Third Homologous or Heterologous Boosting Vaccination in a Longitudinal Cohort.
Journal: Molecular & cellular proteomics : MCP
Published: July 18, 2023
Last Updated: 09/26/2026